drugset / Trial / NCT03107091
Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory Ascites
NaSingle-groupOpen-labelTreatment
Summary
Low-dose continuous infusion of terlipressin will be administered to six cirrhotic patients with refractory ascites.
Timeline
- Start
- 2017-07-15
- Primary completion
- 2019-04-01
- Completion
- 2019-04-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Terlipressin | Peptide | 2 mg | Intravenous |